The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re Agreement

7 Nov 2013 07:00

RNS Number : 4074S
PuriCore Plc
07 November 2013
 



PuriCore plc

 ("PuriCore" or "the Company")

7 November 2013

 

 

PuriCore Lands Second Major US Retailer for FloraFresh

Four-Year Agreement Valued at $3.5 Million

 

PuriCore (LSE: PURI), a global company focused on safe and effective protection against the spread of infectious pathogens, today announces it has signed a new FloraFresh® sales agreement valued at approximately $3.5 million over a four-year term with a second leading US supermarket retailer. The national retailer will use FloraFresh to improve the quality and shelf-life of cut flowers and to decrease labour costs in its stores that have a full floral department. Under terms of agreement, the retailer will begin using FloraFresh late this year and will complete the implementation of this floral programme by the second quarter of 2014. This agreement marks the second major US retailer to use multiple PuriCore products, enhancing both fresh produce and cut flowers, in the vast majority of its stores.

 

Michael Ashton, Executive Chairman, said:

"This second major FloraFresh agreement demonstrates that US supermarket retailers are embracing the value of this product to improve both the quality of their floral offerings as well as their bottom line by reducing inventory waste and cleaning labour. This sale also validates our strategy to increase our footprint in stores of existing customers through our expanded product offerings that deliver similar quality and economic value propositions."

 

About FloraFresh, the Sterilox® Fresh System, and ProduceFresh™

Leading US and Canadian supermarket retailers, including three of the top-five US chains, rely on PuriCore's products to extend shelf-life and to address cross-contamination for fresh produce and flowers. FloraFresh is used to improve the quality and shelf-life of high-margin floral products as well as to reduce the labour associated with cleaning costs. FloraFresh controls the growth of bacteria, viruses, and spoilage organisms, including Pseudomonas, Botrytis (grey mould), and powdery mildew, in floral water to keep floral buckets clean and cut flowers hydrated longer. The Sterilox Fresh System and ProduceFresh offer a natural food-safe rinse that kills harmful pathogens and spoilage organisms, including e.Coli, Salmonella, Listeria, and Norovirus, on contact to keep perishable produce safer and fresher for longer. With extended freshness and shelf-life, these fresh produce products provide labour and inventory cost savings to supermarket retailers.

 

Enquiries:

UK

US

FTI Consulting

Sage Strategic Marketing

Simon Conway/Mo Noonan

Jennifer Guinan

Victoria Foster Mitchell

+1 610.410.8111

+44 (0) 20 7831 3113

jennifer@sagestrat.com

 

 

About PuriCore

PuriCore plc (LSE: PURI) is a global company focused on safe and effective protection against the spread of infectious pathogens without causing harm to human or animal health or to the environment. PuriCore's antimicrobial technology and complementary products are used in well-established core businesses and emerging sectors of two broad markets: Health Sciences and Food & Agriculture. In the Health Sciences market, PuriCore is the leading full provider of all products and services required for a safe, efficient, and compliant endoscope decontamination to protect patients and staff in UK hospitals. PuriCore's breakthrough wound care technology is used to treat chronic and acute wounds including diabetic ulcers and burns in humans, for atopic dermatitis as private-labelled dermatologic treatments for humans, and to manage wounds in all species of companion and large animals in the animal health segment. In the Food & Agriculture market, PuriCore's portfolio is used by three of the top-five US supermarket retailers to provide savings in labour costs and improvements in inventory loss and to address cross contamination of pathogens on fresh produce and floral products. In addition, the Company is progressing its research and development programmes on the use of its technology as an agricultural fungicide. PuriCore is headquartered in Malvern, Pennsylvania, US, with operations in Stafford and Clevedon, UK. To receive additional information on PuriCore, visit www.puricore.com.

 

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions shareholders and prospective shareholders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLFFIILTLRIIV
Date   Source Headline
31st Jan 20139:00 amRNSTotal Voting Rights
17th Jan 20135:22 pmRNSHolding(s) in Company
17th Jan 20134:44 pmRNSHolding(s) in Company
17th Jan 20134:42 pmRNSHolding(s) in Company
17th Jan 20134:37 pmRNSHolding(s) in Company
17th Jan 20134:33 pmRNSHolding(s) in Company
17th Jan 20134:25 pmRNSHolding(s) in Company
17th Jan 20134:24 pmRNSHolding(s) in Company
10th Jan 20134:53 pmRNSBoard Changes
10th Jan 20134:36 pmRNSResult of General Meeting
19th Dec 20123:25 pmRNSPublication of Prospectus
19th Dec 20127:00 amRNSRestructuring of Loan Notes and Placing
19th Nov 20127:00 amRNSInterim Management Statement
15th Nov 20127:00 amRNSLohas partnering agreement
9th Oct 20127:00 amRNSPuriCore Signs Two Major US Deals
3rd Oct 20127:00 amRNSPositive Results from ActiVita Research
15th Aug 20122:34 pmRNSBlocklisting Application
13th Aug 20121:07 pmRNSBlocklisting Interim Review
8th Aug 20121:53 pmRNSNotification of Executive Chairman's Option Grant
6th Aug 20127:00 amRNSHalf Yearly Report
26th Jul 20127:00 amRNSNotice of Results
26th Jun 201211:54 amRNSHolding(s) in Company
25th Jun 20129:00 amRNSDirector's Dealing
12th Jun 201211:36 amRNSResult of AGM
30th May 20127:00 amRNSBoard and Organisational Changes
21st May 20127:00 amRNSAnnual Information Update
30th Apr 20127:00 amRNSDirector Dealing and Share Option Grant
26th Apr 20127:00 amRNSInterim Management Statement
26th Apr 20127:00 amRNSFinal Results
25th Apr 20129:13 amRNSNotice of Results
29th Mar 20127:00 amRNSAppointment of New Chairman and Board Changes
13th Feb 20127:00 amRNSNotification of Director's Details
3rd Feb 20123:22 pmRNSDirectors dealings and share option grants
2nd Feb 20124:59 pmRNSBlocklisting Interim Review
1st Feb 20127:02 amRNSBBSRC Industrial Partner Award
1st Feb 20127:01 amRNSDirectorate Change
1st Feb 20127:00 amRNSPre-Close Trading Update
17th Jan 20127:00 amRNSPuriCore Aqualox EPA confirmation
3rd Jan 20127:00 amRNSRaises $3.5 Million Debt Facility
30th Dec 201110:45 amRNSTotal Voting Rights
19th Dec 20118:31 amRNSPuriCore Receives Two Major Contracts-Replacement
19th Dec 20117:54 amRNSPuriCore Receives Two Major Contracts
14th Dec 20117:00 amRNSAgriculture System Confirmed for Use by EPA
13th Dec 201112:44 pmRNSConvertible loan notes extension
18th Nov 20113:42 pmRNSInterim Management Statement
21st Oct 201111:57 amRNSConvertible Loan Notes Update
10th Oct 20118:21 amRNSHolding(s) in Company
22nd Sep 20114:35 pmRNSBoard and Organisational Changes
16th Sep 201111:19 amRNSNew $1.9million Debt Facility Agreed
5th Sep 20114:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.